These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2746879)
21. Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Osame M; Janssen R; Kubota H; Nishitani H; Igata A; Nagataki S; Mori M; Goto I; Shimabukuro H; Khabbaz R Ann Neurol; 1990 Jul; 28(1):50-6. PubMed ID: 2375633 [TBL] [Abstract][Full Text] [Related]
22. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection]. Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467 [TBL] [Abstract][Full Text] [Related]
24. [Alcoholic cerebellar degeneration with pyramidal sign--in relation to alcoholic myelopathy]. Tsuchiya K; Watabiki S; Shiojiri T; Matsumoto A; Tsukagoshi H No To Shinkei; 1993 Feb; 45(2):169-75. PubMed ID: 8476668 [TBL] [Abstract][Full Text] [Related]
25. Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Mendes GB; Kalil RS; Rosadas C; de Freitas MR; Puccioni-Sohler M Int J Infect Dis; 2014 Aug; 25():1-3. PubMed ID: 24815740 [TBL] [Abstract][Full Text] [Related]
27. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy. Nakamura T Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340 [TBL] [Abstract][Full Text] [Related]
28. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence. Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164 [TBL] [Abstract][Full Text] [Related]
29. [Complete remission achieved by low-dose Ara-C, aclarubicin and rhG-CSF (CAG) therapy in acute non-lymphocytic leukemia with monosomy 7 occurring after severe aplastic anemia]. Yamato H; Yamada K; Koike T; Yoshida M; Tsunogake S; Aoyagi M; Nakamura Y; Watanabe K; Saito K; Enokihara H Rinsho Ketsueki; 1995 Feb; 36(2):128-33. PubMed ID: 7536277 [TBL] [Abstract][Full Text] [Related]
30. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma. Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665 [TBL] [Abstract][Full Text] [Related]
31. Voiding dysfunction in patients with human T-lymphotropic virus type-1-associated myelopathy (HAM). Komine S; Yoshida K; Yamashita H; Masaki Z Paraplegia; 1989 Jun; 27(3):217-21. PubMed ID: 2762009 [TBL] [Abstract][Full Text] [Related]
32. Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy. Hayashi D; Kubota R; Takenouchi N; Nakamura T; Umehara F; Arimura K; Izumo S; Osame M J Neurovirol; 2008 Oct; 14(5):459-63. PubMed ID: 18989817 [TBL] [Abstract][Full Text] [Related]
34. Viral-specific humoral immune responses following transfusion-related transmission of human T cell lymphotropic virus type-I infection. Manns A; Wilks RJ; Hanchard B; Morgan OS; Rudolph DL; Lal RB Viral Immunol; 1994; 7(3):113-20. PubMed ID: 7598784 [TBL] [Abstract][Full Text] [Related]
35. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Osame M; Matsumoto M; Usuku K; Izumo S; Ijichi N; Amitani H; Tara M; Igata A Ann Neurol; 1987 Feb; 21(2):117-22. PubMed ID: 2881513 [TBL] [Abstract][Full Text] [Related]
37. [A patient with marked immunodeficiency in an HTLV-I carrier: a case report]. Iroi A; Miyashita N; Nakamura S; Ohizumi H; Mizuno Y Rinsho Shinkeigaku; 2000 Feb; 40(2):135-9. PubMed ID: 10835933 [TBL] [Abstract][Full Text] [Related]
38. [Acute myelogenous leukemia with recurrence of the meningeal, spinal cord and the optic nerve infiltration with remission induction by Co therapy and maintained by intrathecal chemotherapy with Ommaya reservoir]. Kurituka H; Yokoo K; Kishi A; Mizuno T; Kitani K; Ozawa M; Kobayashi Y; Takanashi Y; Horiuchi H; Maruo N Rinsho Ketsueki; 1989 Oct; 30(10):1898-902. PubMed ID: 2593257 [TBL] [Abstract][Full Text] [Related]
39. Importance of immune deviation toward Th1 in the early immunopathogenesis of human T-lymphotropic virus type I-associated myelopathy. Nakamura T; Furuya T; Nishiura Y; Ichinose K; Shirabe S; Eguchi K Med Hypotheses; 2000 May; 54(5):777-82. PubMed ID: 10859686 [TBL] [Abstract][Full Text] [Related]
40. Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net). Coler-Reilly AL; Yagishita N; Suzuki H; Sato T; Araya N; Inoue E; Takata A; Yamano Y Orphanet J Rare Dis; 2016 May; 11(1):69. PubMed ID: 27225443 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]